Home›Companies›Biotech & Pharma›SiVEC Biotechnologies

SiVEC Biotechnologies, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 17, 2025·Suggest an edit

About SiVEC Biotechnologies

SiVEC Biotechnologies is a private company based in Fort Collins, Colorado, incorporated in 2022 in Delaware. It has reported $3,299,994 raised in one offering on Form D since September 2025. Its chief executive is Lyndsey Linke.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 28, 2025Sep 17, 2025$3,299,994of $5.8M target3$1.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on SiVEC Biotechnologies's Form D filed Sep 17, 2025.

DS
DM
Darcy Mora
Executive officer and director
LL
Lyndsey Linke
Chief Executive Officer and director
SH

Sources

  1. SECSiVEC Biotechnologies, Inc. filing history